To verify the impact of γ-inulin on complement activity in the chosen experimental model, B16BL6 tumours were excised at either 2 or 6 h after treatment and samples prepared by homogenisation of tumour tissue for ELISA-based determination of the levels of C3 protein (key component of the complement cascade). This evidence concerns the gene C3 and neoplasm.